Radical treatment not the only way, NICE stresses in prostate guideline
This article was originally published in Clinica
Executive Summary
The UK Prostate Brachytherapy Advisory Group (PBAG) says that a new guideline on best practice for the diagnosis and treatment of prostate cancer represents a step forward for patient choice. The guideline, issued in late February by the National Institute for Health and Clinical Excellence (NICE), covers the tests, treatment, care and support that men who have suspected or diagnosed prostate cancer should be offered (not care for rare cancers). NICE clinical and public health director Professor